Guy Friedman, co-founder and CEO of SteadyMD
The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking that pattern.
While the fundamentals of healthcare remain the same –…
Continue Reading
News and social media are saturated with articles about the demand for and shortage of glucagon-like peptide-1 (GLP-1) drugs marketed for weight loss. The best-known of these drugs is semaglutide, sold under the brand…
Continue Reading
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received…
Continue Reading
